Results 161 to 170 of about 1,492,362 (344)
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
Author Response: Timing Matters: Caution and Opportunity in Early Vasopressin for Septic Shock. [PDF]
Bhattacharjee A +5 more
europepmc +1 more source
Decision letter for "Consumer expenditure when positional concerns matter"
openalex +1 more source
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié +13 more
wiley +1 more source
Public perception of animal welfare in Iran. [PDF]
Jalali-Motahari AS +3 more
europepmc +1 more source
The social participation of children and adolescents at the local level. The right of the children to be taken into account on matters that concern them [PDF]
Isaac Ravetllat Ballesté +1 more
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Matters arising: a critique of "Nuancing the continuum from ideal to real-world implementation" by Eldh et al. 2025. [PDF]
Nilsen P +3 more
europepmc +1 more source

